A Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in patients with relapsed/refractory and previously untreated mantle cell lymphoma
ENROLLING
Trial ID:
NCT04855695 Protocol # :
21-040
Phase
I/II
Disease Sites
Non-Hodgkin's Lymphoma
Principal Investigator
Kim, Austin, Injae
Site Research Nurses
Aiken, Haley
Aspinwall, Sheridan
Babcock, Elise
Beaver, Rachel, Maureen
Brennan, Lisa
Bresnahan, Caitlin
Bright, Susan
Burke, Candace
Green, Mallory
Kats, Vanessa
Kilcommons, Marykate
Knudsen, Elisabeth
Maciejewski, Ashley, Taylor
Normilus, Samantha
Patterson, Victoria
Re, Sandra
Silva, Wendy, Ann
Smith, Caitlin
Tichon, Jennifer
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-040
21-040